12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
12 health care stocks experienced significant price movements during Wednesday's pre-market session, with 6 gainers and 6 losers. Notable gainers include Aridis Pharmaceuticals, VistaGen Therapeutics, and Marker Therapeutics, while notable losers include Belite Bio, Biodexa Pharmaceuticals, and Bellicum Pharmaceuticals.
May 31, 2023 | 1:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biodexa Pharmaceuticals shares declined by 32.82% to $0.09 during Wednesday's pre-market session.
Biodexa Pharmaceuticals shares experienced a significant decrease in price during the pre-market session, which is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Bellicum Pharmaceuticals shares decreased by 25.09% to $0.57 during Wednesday's pre-market session.
Bellicum Pharmaceuticals shares experienced a significant decrease in price during the pre-market session, which is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
NEGATIVE IMPACT
Belite Bio stock fell 44.0% to $13.39 during Wednesday's pre-market session.
Belite Bio stock experienced a significant decrease in price during the pre-market session, which is likely to have a negative short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Aridis Pharmaceuticals shares increased by 98.9% to $0.37 during Wednesday's pre-market session.
Aridis Pharmaceuticals shares experienced a significant increase in price during the pre-market session, which is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
Marker Therapeutics shares increased by 30.83% to $1.74 during Wednesday's pre-market session.
Marker Therapeutics shares experienced a significant increase in price during the pre-market session, which is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100
POSITIVE IMPACT
VistaGen Therapeutics stock increased by 38.98% to $0.19 during Wednesday's pre-market session.
VistaGen Therapeutics stock experienced a significant increase in price during the pre-market session, which is likely to have a positive short-term impact on the stock.
CONFIDENCE 100
IMPORTANCE 100
RELEVANCE 100